Skip to main content

Tackling substance misuse "too costly for banks"

Costs of reducing operational risk caused by alcohol and drug abuse are "off-putting" to banks despite potentially huge return on investment

pill-bottles

The scale of alcohol and drug misuse in the banking industry is discouraging firms from addressing the problem because of the potential costs involved, a London conference on substance abuse heard yesterday.

John McMahon, chief executive officer at Iloumanate, a consultancy that aims to reduce the cost of alcohol misuse in the workplace, told the conference there was a strong business case for

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Want to know what’s included in our free membership? Click here

Show password
Hide password

Emerging trends in op risk

Karen Man, partner and member of the global financial institutions leadership team at Baker McKenzie, discusses emerging op risks in the wake of the Covid‑19 pandemic, a rise in cyber attacks, concerns around conduct and culture, and the complexities of…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here